Researchers have lab-tested a molecule that can combat the common cold virus by preventing it from hijacking human cells.
Early lab-based tests with human cells have shown the molecule’s ability to completely block multiple strains of cold virus, and the team hope to move to animal and then human trials. The results of initial tests are published today in the journal Nature Chemistry.
A drug like this could be extremely beneficial if given early in infection, and we are working on making a version that could be inhaled, so that it gets to the lungs quickly.Professor Ed Tate
The common cold is caused by a family of viruses with hundreds of variants, making it nearly impossible to become immune to or vaccinate against all of them. On top of that, the viruses evolve rapidly, meaning they can quickly gain resistance to drugs.
For these reasons, most cold remedies rely on treating the symptoms of the infection – such as runny nose, sore throat and fever – rather than tackling the virus itself.
However a new molecule, developed by researchers at Imperial College London, targets N-myristoyltransferase (NMT), a protein in human cells. Viruses ‘hijack’ NMT from human cells to construct the protein ‘shell’, or capsid, which protects the virus genome.
All strains of the virus need this same human protein to make new copies of themselves, so the molecule should work against all of them. Additionally, the molecule also works against viruses related to the cold virus, such as polio and foot and mouth disease viruses.
More than just an inconvenience
The molecule targets a human protein and not the virus itself, making emergence of resistant viruses highly unlikely.
Lead researcher Professor Ed Tate, from the Department of Chemistry at Imperial, said: “The common cold is an inconvenience for most of us, but can cause serious complications in people with conditions like asthma and COPD.
“A drug like this could be extremely beneficial if given early in infection, and we are working on making a version that could be inhaled, so that it gets to the lungs quickly.”
There have been previous attempts to create drugs that target human cells rather than the viruses, but many have the side effect of being toxic. The researchers showed that the new molecule completely blocked several strains of the virus without affecting human cells. Further study is needed to make sure it is not toxic in the body.
The common cold, via malaria and Viagra
The research team included the labs of Professor Roberto Solari and Professor Seb Johnston at Imperial’s National Heart & Lung Institute, Dr Aurelie Mousnier from Imperial and Queen’s University Belfast, structural biologists at the University of York, and colleagues at the Pirbright Institute.
Professor Tate said: “The way the drug works means that we would need to be sure it was being used against the cold virus, and not similar conditions with different causes, to minimise the chance of toxic side effects.”
The medicinal chemistry team in the Tate group at Imperial, led by Dr Andy Bell (who previously invented Viagra as a researcher at Pfizer), were originally looking for compounds that targeted the protein in malaria parasites. Screening large libraries of compounds, they found two hits and were surprised to discover that they worked best together.
By inventing a novel way to combine the two, they created a molecule, codenamed IMP-1088, which is more than a hundred times more potent than previous molecules targeting the protein in humans.
The Latest on: Common cold
via Google News
The Latest on: Common cold
- Out in the cold: Covid-19 preventive measures leading to fewer common flu caseson July 4, 2021 at 12:29 am
Preventive measures such as physical distancing, wearing face masks and hand hygiene are not only preventing the spread of Covid-19, but have helped to reduce cases of the common cold and other ...
- Doctor warns symptoms of COVID-19 Delta variant are similar to 'usual common cold'on July 2, 2021 at 4:36 pm
Doctors are concerned Americans won't get tested not knowing the difference. Commons symptoms of the variant are a headache, runny nose and sore throat.
- Common cold could prime the immune system to fight off Covidon July 2, 2021 at 8:00 am
Some people have natural protection against virus and seem to fight off infection using pre-existing T-cells or ‘immunological dark matter’ ...
- Cough, cold or Covid? As key symptoms merge into one how can you tell when to get tested?on July 1, 2021 at 2:21 pm
KEY coronavirus symptoms have started to shift as different variants take hold across the globe. With that in mind it’s important to understand the newest advice when it comes to symptoms so ...
- Want to get rid of a cold quickly? Drink tulsi kashayam and reap immense benefitson June 30, 2021 at 8:28 pm
Blame the change in season, environmental pollution, or bacterial and viral infections, but let’s just say anyone can get a cold and cough. Although the mild common cold is relatively harmless, it ...
- Common cold or Covid? Upper respiratory symptoms are growing more prevalent, docs sayon June 30, 2021 at 11:48 am
Doctors say even fully vaccinated people need to pay attention to Covid-19 symptoms, such as headache and congestion.
- The return of the common cold: Sales of adult cough medicine has risen 80% compared to 2020on June 30, 2021 at 9:16 am
The flu is returning after a year long hiatus, and Americans are once again purchasing flu and cold related products at the rates that they used to before the COVID-19 pandemic.
- Girl can't walk or talk after mum gets common cold-like virus during pregnancyon June 30, 2021 at 6:47 am
Adrienne Shone, from Bussage, Gloucestershire, spoke of the devastating impact of the cytpmegalovirusm virus which attacks the nervous system of unborn children ...
- Girl can't walk or talk after mother contracts common cold-like CMV viruson June 29, 2021 at 9:55 pm
A mother who picked up a virus when she was pregnant has spoken of the impact it had on her unborn child. Adrienne Shone, 45 from Bussage thought she had just a simple common cold and displayed some ...
via Bing News